ICLR insider trading
NasdaqGS HealthcareICON PLC: insider trade history from SEC Form 4 filings.
About ICON PLC
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Company website: www.iconplc.com
ICLR insider activity at a glance
FilingIQ tracks 50 insider transactions for ICLR in filings since Aug 11, 2026. The most recent transaction is dated Sep 17, 2026.
Across the full history, 0 open-market purchases
and 37 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ICLR insider trades is 62.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ICLR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding ICLR
Frequently asked
- How many insider trades does FilingIQ track for ICLR?
- FilingIQ tracks 50 Form 4 insider transactions for ICLR (ICON PLC), covering filings from Aug 11, 2026 onwards. 50 of those are dated within the last 90 days.
- Are ICLR insiders net buyers or net sellers?
- Across the full Form 4 history for ICLR, 0 transactions (0%) were open-market purchases and 37 (74%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ICLR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ICLR in?
- ICON PLC (ICLR) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $11.48B.
Methodology & sources
Every ICLR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.